Literature DB >> 2411539

The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase.

G Herrler, R Rott, H D Klenk, H P Müller, A K Shukla, R Schauer.   

Abstract

The nature of the receptor-destroying enzyme (RDE) of influenza C virus has been elucidated by analyzing its effect on the haemagglutination inhibitors rat alpha 1-macroglobulin (RMG) and bovine submandibulary mucin (BSM), respectively. The inhibitory activity of both compounds is abolished by incubation with influenza C virus. After inactivation, RMG and BSM were found to contain reduced amounts of N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2) and increased amounts of N-acetylneuraminic acid (Neu5Ac). H.p.l.c. analysis revealed that purified Neu5,9Ac2 is converted to Neu5Ac by incubation with influenza C virus. These results demonstrate that RDE of influenza C virus is neuraminate-O-acetylesterase [N-acyl-9(4)-O-acetylneuraminate O-acetylhydrolase (EC 3.1.1.53)]. The data also indicate that haemagglutination-inhibition (HI) by RMG and BSM and most likely virus attachment to cell surfaces involves binding of influenza C virus to Neu5,9Ac2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411539      PMCID: PMC554374          DOI: 10.1002/j.1460-2075.1985.tb03809.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  15 in total

1.  Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae.

Authors:  A GOTTSCHALK
Journal:  Biochim Biophys Acta       Date:  1957-03

Review 2.  Characterization of sialic acids.

Authors:  R Schauer
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

3.  Properties of the erythrocyte receptors for influenza C virus.

Authors:  M Ohuchi; M Homma; M Muramatsu; S Ohyama
Journal:  Microbiol Immunol       Date:  1978       Impact factor: 1.955

4.  The nature of sialic acids in human lymphocytes.

Authors:  J P Kamerling; J Makovitzky; R Schauer; J F Vliegenthart; M Wember
Journal:  Biochim Biophys Acta       Date:  1982-02-02

Review 5.  Chemistry, metabolism, and biological functions of sialic acids.

Authors:  R Schauer
Journal:  Adv Carbohydr Chem Biochem       Date:  1982       Impact factor: 12.200

6.  A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides.

Authors:  A P Kendal
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

7.  A precursor glycoprotein in influenza C virus.

Authors:  G Herrler; R W Compans; H Meier-Ewert
Journal:  Virology       Date:  1979-11       Impact factor: 3.616

8.  Rat alpha 1 macroglobulin inhibits hemagglutination by influenza C virus.

Authors:  G Herrler; R Geyer; H P Müller; S Stirm; H D Klenk
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

9.  Neuraminic acid is involved in the binding of influenza C virus to erythrocytes.

Authors:  G Herrler; R Rott; H D Klenk
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

10.  New sialic acids. Identification of N-glycoloyl-O-acetylneuraminic acids and N-acetyl-O-glycoloylneuraminic acids by improved methods for detection of N-acyl and O-acyl groups and by gas-liquid chromatography.

Authors:  H P Buscher; J Casals-Stenzel; R Schaufer
Journal:  Eur J Biochem       Date:  1974-12-16
View more
  89 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

2.  Initial events in infectious salmon anemia virus infection: evidence for the requirement of a low-pH step.

Authors:  T M Eliassen; M K Frøystad; B H Dannevig; M Jankowska; A Brech; K Falk; K Romøren; T Gjøen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Highly efficient chemoenzymatic synthesis of naturally occurring and non-natural alpha-2,6-linked sialosides: a P. damsela alpha-2,6-sialyltransferase with extremely flexible donor-substrate specificity.

Authors:  Hai Yu; Shengshu Huang; Harshal Chokhawala; Mingchi Sun; Haojie Zheng; Xi Chen
Journal:  Angew Chem Int Ed Engl       Date:  2006-06-12       Impact factor: 15.336

4.  Comparison of hemagglutinating, receptor-destroying, and acetylesterase activities of avirulent and virulent bovine coronavirus strains.

Authors:  J Storz; X M Zhang; R Rott
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  The hemagglutinin/esterase glycoprotein of bovine coronaviruses: sequence and functional comparisons between virulent and avirulent strains.

Authors:  X M Zhang; K G Kousoulas; J Storz
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

6.  Structure and orientation of expressed bovine coronavirus hemagglutinin-esterase protein.

Authors:  T E Kienzle; S Abraham; B G Hogue; D A Brian
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Uptake and incorporation of an epitope-tagged sialic acid donor into intact rat liver Golgi compartments. Functional localization of sialyltransferase overlaps with beta-galactosyltransferase but not with sialic acid O-acetyltransferase.

Authors:  R Chammas; J M McCaffery; A Klein; Y Ito; L Saucan; G Palade; M G Farquhar; A Varki
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

8.  The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant.

Authors:  B Schultze; H J Gross; R Brossmer; G Herrler
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Crystal structure of phage P22 tailspike protein complexed with Salmonella sp. O-antigen receptors.

Authors:  S Steinbacher; U Baxa; S Miller; A Weintraub; R Seckler; R Huber
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase.

Authors:  Annaiah Cariappa; Hiromu Takematsu; Haoyuan Liu; Sandra Diaz; Khaleda Haider; Cristian Boboila; Geetika Kalloo; Michelle Connole; Hai Ning Shi; Nissi Varki; Ajit Varki; Shiv Pillai
Journal:  J Exp Med       Date:  2008-12-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.